Hematology: Aggressive T-cell lymphoma — Chemotherapy. Treatment
T-cell lymphomas account for about 15% of non-Hodgkin's lymphoma. These tumors may have both indolent and aggressive forms. In the first case, the patients usually do not require an immediate treatment; medical supervision is sufficient. In the second case, the disease develops rapidly, so the oncologists recommend immediate chemotherapy.
The treatment is preceded by a thorough diagnostics. The clinic professional examines the lymph nodes. Then s/he interviews the patient about his/her disease and lifestyle. The following tests are also prescribed:
- complete blood count,
- blood chemistry,
- cytogenetic analysis.
Based on these data, the physician selects the optimal therapy program.
The treatment is carried out in a hospital setting. The average cycle duration is 5 days. The required number of cycles and their intensity is determined by the attending oncologist.
The regimen choice is determined by disease severity. Typically, the patients are administered 5 to 6 cytostatics at once with a different mechanism of action. This ensures the highest possible efficiency of protection against the tumor cells.
The drugs are administered by infusion. The most common side effects reported by patients are:
- increased susceptibility to infections.
In order to eliminate the adverse phenomena, a symptomatic therapy is administered. The nursing staff of the clinic provides an ongoing monitoring and care of the patient.
The timely treatment allows achieving remission in more than 70% patients. The further tactics of actions is discussed individually in each case.Hide
Haven't found Your diagnosis yet?
Send an inquiry to get a cost estimate on: